| PDF files are provided to produce high quality copies of our
products. These may be viewed with a free copy of
Adobe
Acrobat Reader. |
MDMA (Ecstasy) Fast Facts
March 2003
Product No. 2002-L0559-001
html
pdf
(759 KB)
En Espaņol 2005-L0508-001
html
pdf
(64 KB)
This trifold brochure answers the common questions about MDMA.
It includes a description of the drug, describes the risks of abuse
and presents a profile of the typical abuser. Also included is a
list of street terms.
MDMA in New England--Information Bulletin
July 2001
Product No. 2001-L0424-006
html
pdf
(455 KB)
This document discusses the abuse, availability,
distribution, production, and transportation of MDMA in New England.
PCP Tablets Sold as MDMA--Information
Bulletin
April 2001
Product No. 2001-L0424-003
html
pdf
(272 KB)
This bulletin informs the law enforcement and treatment communities
about the nontraditional distribution of the hallucinogen PCP
(phencyclidine). In one recent case, PCP was distributed as the club
drug MDMA (3,4-methylenedioxymethamphetamine) in the Washington,
D.C., metropolitan area. In another, tablets containing PCP,
ketamine, ephedrine, and caffeine were being sold as MDMA in Upstate
New York.
To Top
Methadone Abuse Increasing--Information
Bulletin
September 2003
Product No. 2003-L0424-004
html
pdf
(236 KB)
This Information Bulletin addresses an
apparent rise in methadone abuse and
examines the methods by which abusers acquire this drug.
Methadone Fast Facts
September 2003
Product No. 2003-L0559-021
html
pdf
(166 KB)
En Espaņol 2005-L0508-021
html
pdf
(56 KB)
This trifold brochure answers common questions about methadone. It
includes a description of the drug, describes the risks of abuse,
how the drug is obtained, and presents a profile of the typical
abuser. Also included is a list of street terms.
To Top
Be Aware! Products from your store may
be used to produce methamphetamine--Methamphetamine Poster
May 2003 pdf
(1,097 KB)
This poster alerts store owners about products that can be
used in manufacturing methamphetamine.
Crystal Methamphetamine
Fast Facts
June 2003
Product No. 2003-L0559-012
html
pdf (160
KB)
En Espaņol 2005-L0508-012
html
pdf
(76 KB)
This trifold brochure answers the common questions about
crystal methamphetamine. It includes a description of the drug,
describes the risks of abuse and presents a profile of the typical
abuser. Also included is a list of street terms.
Crystal Methamphetamine--Information
Bulletin
August 2002
Product No. 2002-L0424-005
html
pdf
(280 KB)
En Espaņol 2003-L0508-003
html
pdf
(261 KB)
This information bulletin provides an update on the availability of,
demand for, production, transportation, and distribution of crystal
methamphetamine.
Marijuana and Methamphetamine
Trafficking on Federal Lands Threat Assessment
February 2005
Product No. 2005-Q0317-007
html
pdf
(2,170 KB)
This report provides an assessment of marijuana cultivation and
methamphetamine production occurring on and transportation through
public federal lands.
Methamphetamine Fast Facts
April 2003
Product No. 2003-L0559-006
html
pdf
(433 KB)
En Espaņol 2005-L0508-006
html
pdf
(58 KB)
This trifold brochure answers the common questions about
methamphetamine. It includes a description of the drug, describes
the risks of abuse and presents a profile of the typical abuser.
Also included is a list of street terms.
Methamphetamine Laboratory Identification and Hazards Fast Facts
December 2003
Product No. 2004-L0559-001
html
pdf
(192 KB)
En Espaņol 2005-L0508-028
html
pdf
(60 KB)
This brochure answers the common questions asked about
methamphetamine laboratory identification and hazards such as what
is a methamphetamine laboratory, how common are they, where are they
found, what are the signs, what are the hazards and what can I do?
Also included is a chart of chemicals with their associated hazards
and a chart of products and equipment used in methamphetamine
production.
To Top
2C-T-7 Fast Facts
November 2004
Product No. 2004-L0559-008
html
pdf
(142 KB)
This trifold brochure answers common questions asked about
2C-T-7. It includes a description of the drug, describes the risks
of abuse, and presents a profile of the typical abuser. Also
included is a list of street terms.
5-MeO-AMT Fast Facts
June 2004
Product No. 2004-L0559-002
html
pdf
(59 KB)
This trifold brochure answers the common questions asked
about 5-MeO-AMT. It includes a description of the drug, describes
the risks of abuse, and presents a profile of the typical abuser.
AMT Fast Facts
May 2004
Product No. 2004-L0559-003
html
pdf
(47 KB)
This trifold brochure answers common questions asked about
AMT. It includes a description of the drug, describes the risks of
abuse, and presents a profile of the typical abuser. Also included
is a list of street terms.
Buprenorphine: Potential for
Abuse--Intelligence Bulletin
September 2004
Product No. 2004-L0424-013
html
pdf
(370 KB)
This bulletin addresses the use of buprenorphine, a drug
recently approved for use in opiate addiction therapy. It examines
the drug's effects, advantages of traditional treatment options, and
vulnerability to diversion and abuse.
BZP Fast Facts
September 2004
Product No. 2004-L0559-007
html
pdf
(69 KB)
This trifold brochure answers the common questions about BZP.
It includes a description of the drug, describes the risks of abuse
and presents a profile of the typical abuser. Also included is a
list of street terms.
Drug Paraphernalia Fast
Facts
September 2003
Product No. 2003-L0559-025
html pdf
(494 KB)
En Espaņol 2005-L0508-025
html
pdf
(124 KB)
This trifold brochure answers the common questions about drug
paraphernalia.
Drugs and Gangs Fast Facts
January 2005
Product No. 2005-L0559-001
html
pdf
(122 KB)
This trifold brochure answers common questions asked about drugs and
gangs. It discusses the relation between drugs and gangs, describes
the extent of gang operation and crime in the United States, and the
dangers associated with gang activity. In addition it describes
signs that may indicate youth involvement in gang activity.
Foxy Fast Facts
September 2003
Product No. 2003-L0559-024
html
pdf
(187 KB)
En Espaņol 2005-L0508-024
html
pdf
(78 KB)
This trifold brochure answers common questions about foxy. It
includes a description of the drug, describes the risks of abuse,
how the drug is obtained, and presents a profile of the typical
abuser.
Fry Fast Facts
November 2004
Product No. 2004-L0559-009
html
pdf
(111 KB)
This trifold brochure answers common questions asked about
2C-T-7. It includes a description of the drug, describes the risks
of abuse, and presents a profile of the typical abuser. Also
included is a list of street terms.
To Top
Psilocybin Fast Facts
August 2003
Product No. 2003-L0559-018
html
pdf
(161 KB)
En Espaņol 2005-L0508-018
html
pdf
(68 KB)
This trifold brochure answers common questions about
psilocybin. It includes a description of the drug, describes the
risks of abuse, how the drug is obtained, and presents a profile of
the typical abuser. Also included is a list of street terms.
Ritalin Fast Facts
September 2003
Product No. 2003-L0559-026
html
pdf
(311 KB)
En Espaņol 2005-L0508-026
html
pdf
(50 KB)
This trifold brochure answers common questions about Ritalin.
It includes a description of the drug, describes the risks of abuse,
how the drug is obtained, and presents a profile of the typical
abuser. Also included is a list of street terms.
Rohypnol Fast Facts - Revised
August 2003
Product No. 2003-L0559-020
html
pdf
(250 KB)
This trifold brochure answers common questions about
Rohypnol. It includes a description of the drug, describes the risks
of abuse, how the drug is obtained, and presents a profile of the
typical abuser. Also included is a list of street terms.
Soma Fast Facts
September 2004
Product No. 2004-L0559-006
html
pdf
(39 KB)
This trifold brochure answers the common questions about
Soma. It includes a description of the drug, describes the risks of
abuse and presents a profile of the typical abuser. Also included is
a list of street terms.
Teens and Drugs Fast Facts
November 2004
Product No. 2004-L0559-011
html
pdf
(51 KB)
This trifold brochure answers common questions asked about
teens and drugs. It discusses the significance of teen drug abuse,
the correlation between age of first drug sue and dependence, the
risks specific to marijuana and other illicit drugs.
Triple C Fast Facts
November 2003
Product No. 2003-L0559-028
html
pdf
(143 KB)
En Espaņol 2005-L0508-027
html
pdf
(119 KB)
This trifold brochure answers common questions about Triple
C. It includes a description of the drug, describes the risks of
abuse, how the drug is obtained, and presents a profile of the
typical abuser. Also included is a list of street terms.
To Top
OxyContin Diversion and
Abuse--Information Bulletin
January 2001
Product No. 2001-L0424-001
html
pdf
(711 KB)
This bulletin addresses the diversion and abuse of the
prescription pain reliever OxyContin and the impact of abuse,
particularly in the eastern United States.
OxyContin Diversion, Availability, and
Abuse--Intelligence Bulletin
August 2004
Product No. 2004-L0424-017
html
pdf
(525 KB)
This report provides an assessment of OxyContin diversion and
abuse in the United States.
OxyContin Fast Facts
August 2003
Product No. 2003-L0559-019
html
pdf
(789 KB)
En Espaņol
2005-L0508-019
html
pdf
(107 KB)
This trifold brochure answers the common questions about
OxyContin. It includes a description of the drug, describes the
risks of abuse and presents a profile of the typical abuser. Also
included is a list of street terms.
To Top
PCP Fast Facts
May 2003
Product No. 2003-L0559-008
html
pdf
(425 KB)
This trifold brochure answers the common questions about PCP.
It includes a description of the drug, describes the risks of abuse
and presents a profile of the typical abuser. Also included is a
list of street terms.
PCP: Increasing Availability and
Abuse--Intelligence Bulletin
September 2004
Product No. 2004-L0424-002
html
pdf
(331 KB)
This Intelligence Bulletin provides law enforcement, seizure,
and treatment data indicating that PCP availability and abuse are
increasing in some areas of the country, particularly in
metropolitan areas. Though considered a minor threat in comparison
to other illicit drugs, the resurgence of PCP poses a significant
threat to the United States.
PCP Tablets Sold as MDMA--Information
Bulletin
April 2001
Product No. 2001-L0424-003
html
pdf
(272 KB)
This bulletin informs the law
enforcement and treatment communities about the nontraditional
distribution of the hallucinogen PCP (phencyclidine). In one recent
case, PCP was distributed as the club drug MDMA
(3,4-methylenedioxymethamphetamine) in the Washington, D.C.,
metropolitan area. In another, tablets containing PCP, ketamine,
ephedrine, and caffeine were being sold as MDMA in Upstate New York.
To Top
Pharmaceuticals Drug Threat Assessment
November 2004
Product No. 2004-L0487-001
html
pdf
(8,472 KB)
This report provides an assessment of prescription drug
availability, diversion, and abuse. Also discussed are the threats
posed by doctor shopping, prescription fraud, unscrupulous
physicians, theft, and internet pharmacies
Prescription Drugs Fast
Facts
July 2003
Product No. 2003-L0559-013
html
pdf
(702 KB)
En Espaņol 2005-L0508-013
html
pdf
(58 KB)
This trifold brochure answers common questions about
prescription drug abuse. It includes a description of the drugs,
describes the risks of abuse, how the drugs are obtained, and
presents a profile of the typical abuser. Also included is a list of
street terms.
To Top
Steroids Fast Facts
July 2003
Product No. 2003-L0559-017
html
pdf
(297 KB)
En Espaņol 2005-L0508-017
html
pdf
(99 KB)
This trifold brochure answers the common questions about
steroids. It includes a description of the drug, describes the risks
of abuse and presents a profile of the typical abuser. Also included
is a list of street terms.
To Top
Yaba Fast Facts
June 2003
Product No. 2003-L0559-015
html
pdf (177
KB)
En Espaņol 2005-L0508-015
html
pdf
(158 KB)
This trifold brochure answers the common questions about Yaba.
It includes a description of the drug, describes the risks of abuse
and presents a profile of the typical abuser. Also included is a
list of street terms.
|
